Efficacy of recombinant human soluble thrombomodulin in preventing walled-off necrosis in severe acute pancreatitis patients

Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
Takaaki EguchiAkihiko Okada

Abstract

To investigate the efficacy of recombinant human soluble thrombomodulin (rTM) in preventing the development of walled-off necrosis (WON) in severe acute pancreatitis (SAP) patients. We retrospectively analyzed 54 SAP patients divided into two groups: SAP patients treated by rTM (rTM group, 24 patients) and not treated by rTM (control group, 30 patients). rTM was administered to patients with disseminated intravascular coagulation (DIC). Initially, on the admission day, we recorded patient severity and pancreatic necrosis/ischemia positive or negative. Then we investigated development of WON using 4 weeks later CT/MRI. Finally we compared the proportions of patients developing WON in the rTM group and the control group. On the admission day, the condition of patients treated by rTM was significantly worse than patients in the control group; rTM group vs. 71.8 ± 13.9 vs. 59.8 ± 15.3 years for age, 10.7 ± 3.5 vs. 8.0 ± 4.4 for Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and 3.3 ± 1.8 vs. 2.2 ± 1.8 for sequential organ failure assessment (SOFA) score (p < 0.05). We found no significant differences on the admission day in rate of pancreatic necrosis/ischemia between patients treated by rTM and controls (58.3...Continue Reading

References

May 6, 1999·The New England Journal of Medicine·T H Baron, D E Morgan
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Jul 18, 2002·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·K TakedaS Matsuno
May 6, 2005·Nature Medicine·Charles Esmon
Feb 8, 2006·Journal of Hepato-biliary-pancreatic Surgery·Masaru KoizumiUNKNOWN JPN
Feb 8, 2006·Journal of Hepato-biliary-pancreatic Surgery·Masahiko HirotaUNKNOWN JPN
Feb 8, 2006·Journal of Hepato-biliary-pancreatic Surgery·Kazunori TakedaUNKNOWN JPN
Feb 8, 2006·Journal of Hepato-biliary-pancreatic Surgery·Toshihiko MayumiUNKNOWN JPN
Nov 18, 2006·Blood·Laurent O MosnierJohn H Griffin
Jan 15, 2008·Lancet·Jean-Louis FrossardCatherine M Pastor
Apr 5, 2008·Current Opinion in Critical Care·James R A Skipworth, Stephen P Pereira
Dec 17, 2009·Critical Care : the Official Journal of the Critical Care Forum·Toshiaki IbaYoichi Ohno
Apr 10, 2010·World Journal of Gastroenterology : WJG·Michael StamatakosMichael Safioleas
Jul 29, 2010·Critical Care : the Official Journal of the Critical Care Forum·Ville PettiläEsko Kemppainen
May 17, 2011·Critical Care : the Official Journal of the Critical Care Forum·Kazuma YamakawaTakeshi Shimazu
Apr 21, 2012·International Journal of Inflammation·Yoshihisa TsujiChiba Tsutomu
Oct 27, 2012·Gut·Peter A BanksUNKNOWN Acute Pancreatitis Classification Working Group
Apr 23, 2014·International Journal of Laboratory Hematology·M Levi
Oct 21, 2014·The British Journal of Surgery·P Sarathi PatraG K Dhali
Dec 17, 2014·Cellular Immunology·Ziaurahman RoeenEsteban C Gabazza

❮ Previous
Next ❯

Citations

Feb 18, 2017·International Journal of Molecular Sciences·Paulina DumnickaBeata Kuśnierz-Cabala
Apr 22, 2017·International Journal of Molecular Sciences·Zygmunt WarzechaArtur Dembiński
Jun 9, 2020·Journal of Hepato-biliary-pancreatic Sciences·Satoshi IkarashiShuji Terai
Jul 30, 2017·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Yuhei IrieAtsufumi Kawabata

❮ Previous
Next ❯

Related Concepts

Related Feeds

Canavan Disease

Canavan disease, a type of leukodystrophy, is an autosomal recessive neurodegenerative disorder, and is one of the most common degenerative cerebral diseases of infancy. Discover the latest research on Canavan disease here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.